Kerstin Hermelink
Kerstin Hermelink
Department of Gynecology and Obstetrics, Ludwig Maximilian University of Munich
Dirección de correo verificada de
Citado por
Citado por
Cognitive function during neoadjuvant chemotherapy for breast cancer: results of a prospective, multicenter, longitudinal study
K Hermelink, M Untch, MP Lux, R Kreienberg, T Beck, I Bauerfeind, ...
Cancer 109 (9), 1905-1913, 2007
Two different sides of ‘chemobrain’: determinants and nondeterminants of self‐perceived cognitive dysfunction in a prospective, randomized, multicenter study
K Hermelink, H Küchenhoff, M Untch, I Bauerfeind, MP Lux, M Bühner, ...
Psycho‐Oncology 19 (12), 1321-1328, 2010
Short‐term effects of treatment‐induced hormonal changes on cognitive function in breast cancer patients: results of a multicenter, prospective, longitudinal study
K Hermelink, V Henschel, M Untch, I Bauerfeind, MP Lux, K Munzel
Cancer 113 (9), 2431-2439, 2008
Elucidating pretreatment cognitive impairment in breast cancer patients: the impact of cancer-related post-traumatic stress
K Hermelink, V Voigt, J Kaste, F Neufeld, R Wuerstlein, M Bühner, ...
Journal of the National Cancer Institute 107 (7), djv099, 2015
Chemotherapy and post-traumatic stress in the causation of cognitive dysfunction in breast cancer patients
K Hermelink, M Bühner, P Sckopke, F Neufeld, J Kaste, V Voigt, K Münzel, ...
JNCI: Journal of the National Cancer Institute 109 (10), djx057, 2017
Chemotherapy and cognitive function in breast cancer patients: the so-called chemo brain
K Hermelink
Journal of the National Cancer Institute Monographs 2015 (51), 67-69, 2015
Clinically assessed posttraumatic stress in patients with breast cancer during the first year after diagnosis in the prospective, longitudinal, controlled COGNICARES study
V Voigt, F Neufeld, J Kaste, M Bühner, P Sckopke, R Wuerstlein, ...
Psycho‐Oncology 26 (1), 74-80, 2017
Menopausal Status in Breast Cancer Patients with Past Chemotherapy Determines Long‐Term Hypoactive Sexual Desire Disorder
R Ochsenkühn, K Hermelink, AH Clayton, V von Schönfeldt, J Gallwas, ...
The Journal of Sexual Medicine 8 (5), 1486-1494, 2011
Immunotherapy: new options in breast cancer treatment
M Untch, N Ditsch, K Hermelink
Informa Healthcare 3 (3), 403-408, 2003
International expert consensus on primary systemic therapy in the management of early breast cancer: Highlights of the Fifth Symposium on Primary Systemic Therapy in the …
V Amoroso, D Generali, T Buchholz, M Cristofanilli, R Pedersini, ...
JNCI Monographs 2015 (51), 90-96, 2015
Increased trace amine-associated receptor 1 (TAAR1) expression is associated with a positive survival rate in patients with breast cancer
A Vattai, E Akyol, C Kuhn, S Hofmann, H Heidegger, F von Koch, ...
Journal of cancer research and clinical oncology 143 (9), 1637-1647, 2017
Reply to Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer
JS Wefel, CA Meyers
Cancer 117 (5), 1103-1104, 2011
EP3 (prostaglandin E2 receptor 3) expression is a prognostic factor for progression-free and overall survival in sporadic breast cancer
A Semmlinger, V von Schoenfeldt, V Wolf, A Meuter, TM Kolben, T Kolben, ...
BMC cancer 18 (1), 1-9, 2018
TAAR1 induces a disturbed GSK3β phosphorylation in recurrent miscarriages through the ODC
S Stavrou, M Gratz, E Tremmel, C Kuhn, S Hofmann, H Heidegger, ...
Endocrine connections 7 (2), 372-384, 2018
Factors associated with the decline of psychological support in hospitalized patients with cancer
T Pichler, A Dinkel, B Marten‐Mittag, K Hermelink, E Telzerow, ...
Psycho‐Oncology, 2019
Investigation of RIP140 and LCoR as independent markers for poor prognosis in cervical cancer
A Vattai, V Cavailles, S Sixou, S Beyer, C Kuhn, M Peryanova, ...
Oncotarget 8 (62), 105356, 2017
Thyronamine regulation of TAAR1 expression in breast cancer cells and investigation of its influence on viability and migration
E Tremmel, S Hofmann, C Kuhn, H Heidegger, S Heublein, K Hermelink, ...
Breast Cancer: Targets and Therapy 11, 87, 2019
Brief Distress Screening in Clinical Practice: Does it Help to Effectively Allocate Psycho-Oncological Support to Female Cancer Inpatients?
K Hermelink, H Höhn, S Hasmüller, J Gallwas, K Haertl, R Wuerstlein, ...
Breast Care 9 (2), 129-129, 2014
Dopamine synthesis and dopamine receptor expression are disturbed in recurrent miscarriages
MJ Gratz, S Stavrou, C Kuhn, S Hofmann, K Hermelink, H Heidegger, ...
Endocrine connections 7 (5), 727-738, 2018
Listening: Reflections on a Series of Counseling Sessions
K Hermelink
Journal of Clinical Oncology 30 (5), 558-559, 2012
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20